Reported Reactions

Devices › Device types

FDA product code FAD · class 2 · Gastroenterology, Urology

Stent, ureteral: medical device reports filed with FDA

5,909 reports carry this product code, 1993–2026; 22 brands with a page.

5,909
reports with this product code
0% of all MAUDE reports
616
reports, 12 months to August 2026
652 in the 12 months before
70.6%
classified as malfunction
62.3% across all reports
0.2%
classified as death, as reported
0.9% across all reports

Product code FAD is FDA's classification for "Stent, ureteral" (gastroenterology, Urology panel), a class 2 device. 5,909 medical device reports carry this product code, 0% of the MAUDE database, from September 1993 to August 2026.

616 reports arrived in the 12 months to August 2026, close to the 652 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (70.6%), injury (28.5%) and other (0.5%). 22 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Polaris? Ultra478490%83.1%
Bard InLay Optima Ureteral Stent394440%79.2%
Bard InLay Ureteral Stent with HydroGlide Guidewire342170%86.5%
Percuflex Plus301500.4%67.2%
Resonance Stent Set256161.2%21.1%
Bard InLay Ureteral Stent232250%69.8%
Filiform Double Pigtail Ureteral Stent Set225380.4%81.1%
Bard InLay Optima Ureteral Stent with HydroGlide Guidewire220140%88.6%
Universa Soft Ureteral Stent Set204140%73.7%
Universa Firm Ureteral Stent Set203120%61.1%
Contour157380%85.3%
Polaris? Loop154250.6%93.5%
Flexima?20100.4%75.5%
Boston Scientific453.3%55%
Cotton-Leung Biliary Stent3201.1%55.7%
Cook262.2%45%
Bard121.8%31.1%
Bardex Foley Catheter Silicone Coated13060.1%93.9%
Evolution Biliary Controlled-Release Stent - Fully Covered1990.2%83.7%
Evolution Duodenal Controlled-Release Stent - Uncovered150.5%52.7%
Olympus192.5%69.7%
Zimmon Pancreatic Stent160%85.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
C R Bard Covington -10182331,39323.6%
Cook66711.3%
Boston Scientific - Costa Rica Coyol2955%
Cook Ireland2884.9%
Coloplast A/S1973.3%
Productos Para El Cuidado De La Salud -9611590601%
C R Bard430.7%
Boston Scientific - Costa Rica210.4%
Applied Medical150.3%
Applied Medical Resources140.2%
Teleflex Medical110.2%
Gyrus Acmi90.2%
Boston Scientific50.1%
American Medical Systems40.1%
Angiomed & Medizintechnik Kg40.1%

Reports by month, five years

062124Sep 2021: 40Oct 2021: 101Nov 2021: 124Dec 2021: 532022Jan 2022: 30Feb 2022: 42Mar 2022: 41Apr 2022: 78May 2022: 37Jun 2022: 38Jul 2022: 36Aug 2022: 52Sep 2022: 70Oct 2022: 39Nov 2022: 55Dec 2022: 412023Jan 2023: 57Feb 2023: 48Mar 2023: 67Apr 2023: 50May 2023: 55Jun 2023: 75Jul 2023: 66Aug 2023: 43Sep 2023: 42Oct 2023: 58Nov 2023: 69Dec 2023: 612024Jan 2024: 48Feb 2024: 45Mar 2024: 45Apr 2024: 45May 2024: 29Jun 2024: 61Jul 2024: 56Aug 2024: 46Sep 2024: 51Oct 2024: 56Nov 2024: 57Dec 2024: 642025Jan 2025: 51Feb 2025: 39Mar 2025: 43Apr 2025: 49May 2025: 36Jun 2025: 60Jul 2025: 69Aug 2025: 77Sep 2025: 54Oct 2025: 56Nov 2025: 40Dec 2025: 622026Jan 2026: 47Feb 2026: 42Mar 2026: 52Apr 2026: 73May 2026: 44Jun 2026: 57Jul 2026: 38Aug 2026: 51

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.2%9
Injury28.5%1,686
Malfunction70.6%4,171
Other0.5%30
Not given0.2%13

Who filed

Manufacturer report94.5%5,583
Voluntary report2.1%123
User facility report0%0
Distributor report0.7%44
Not given2.7%159

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Breakthe device broke1,42724.1%
Material fragmentation59510.1%
Calcified4728%
Difficult to removethe device was hard to remove4046.8%
Material separation2464.2%
Material split, cut or torn2323.9%
Difficult to advance2133.6%
Detachment of device or device componentpart of the device came off2123.6%
Material deformation2003.4%
Migrationthe device moved from where it was placed1712.9%
Deformation due to compressive stress1682.8%
Patient device interaction problem1282.2%
Fracturea broken bone1252.1%
Biocompatibility991.7%
Detachment of device component971.6%
Migration or expulsion of device941.6%
Replace871.5%
Device damaged prior to usethe device was damaged before use741.3%
Torn material741.3%
Nonstandard device701.2%

Questions about stent, ureteral reports

What is product code FAD?

FDA's classification code for "Stent, ureteral", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.

How many reports carry this code?

5,909 reports through August 2026, 616 of them in the latest 12 months.

Which brands appear most often?

Polaris? Ultra (478), Bard InLay Optima Ureteral Stent (394), Bard InLay Ureteral Stent with HydroGlide Guidewire (342), Percuflex Plus (301) and Resonance Stent Set (256). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.